HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Iatrogenic benign lymphoplasia induced by allergic contact dermatitis from squaric acid dibutylester: immunohistologic study of cellular infiltrates.

Abstract
We report of a 62-year-old male patient with a dull red itchy nodule on the induction area of allergic contact dermatitis to squaric acid dibutylester, which had been used for the therapy of alopecia universalis. The excised biopsy specimen showed dense infiltration of lymphoid cells in the dermis and subcutaneous tissue, associated with the formation of lymphoid follicles. Immunohistologic analysis of the infiltrates indicated mixed proliferation of T- and B-cells. A biopsy specimen from the challenge area showed spongiosis in the epidermis and lymphoid cell infiltration in the upper dermis, while the infiltrates consisted mainly of T-cells. The following points are discussed: (i) the lesion had an iatrogenic origin and the causative agent was quite evident; (ii) the route of allergen application was only through the epidermis and not directly in the dermis; (iii) lymphoid cell infiltrates of the induction and challenge areas were different.
AuthorsK Nishioka, M Ogasawara, K Kurata, C Asagami
JournalContact dermatitis (Contact Dermatitis) Vol. 28 Issue 1 Pg. 3-5 (Jan 1993) ISSN: 0105-1873 [Print] England
PMID8428442 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Allergens
  • Cyclobutanes
  • squaric acid dibutyl ester
Topics
  • Allergens (adverse effects)
  • Alopecia (drug therapy)
  • B-Lymphocytes (pathology)
  • Cell Division
  • Cell Movement
  • Cyclobutanes (adverse effects, therapeutic use)
  • Dermatitis, Allergic Contact (etiology, pathology)
  • Drug Eruptions (etiology, pathology)
  • Humans
  • Iatrogenic Disease
  • Immunohistochemistry
  • Male
  • Middle Aged
  • T-Lymphocytes (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: